T1	HMM 697 783	better anatomic (six months) and visual (six and 24 months) outcomes and less hypotony
T2	HMM 896 932	decreased the likelihood of hypotony
T3	HMM 1100 1131	proliferative vitreoretinopathy
T4	HMM 1451 1469	equally effective.
